Stroke recurrence in children with sickle cell disease treated with hydroxyurea following first clinical stroke (Q50180616)

26 February 2018

title

Stroke recurrence in children with sickle cell disease treated with hydroxyurea following first clinical stroke (English)

1 reference

26 February 2018

0 references

1 reference

5

1 reference

26 February 2018

Lesley King

3

object named as

Lesley King

1 reference

26 February 2018

Jennifer M Knight-Madden

4

object named as

Jennifer Knight-Madden

1 reference

26 February 2018

author name string

Susanna Bortolusso Ali

1

1 reference

26 February 2018

Michelle Moosang

2

1 reference

26 February 2018

publication date

2 September 2011

1 reference

26 February 2018

American Journal of Hematology

published in

1 reference

26 February 2018

volume

86

1 reference

26 February 2018

issue

10

1 reference

26 February 2018

page(s)

846-850

1 reference

26 February 2018

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

cites work

1 reference

Neonatal screening for sickle cell disease in France.

21 January 2018

1 reference

Neonatal haemoglobinopathy screening in Spain

21 January 2018

1 reference

Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005-7.

21 January 2018

1 reference

Newborn sickle cell disease screening: the Jamaican experience (1995-2006).

21 January 2018

1 reference

Management of sickle cell disease; lessons from the Jamaican Cohort Study

21 January 2018

1 reference

Stroke in a cohort of patients with homozygous sickle cell disease

21 January 2018

1 reference

Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke

21 January 2018

1 reference

Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort

21 January 2018

1 reference

Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).

21 January 2018

1 reference

Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial

21 January 2018

1 reference

Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.

21 January 2018

1 reference

Five years of experience with hydroxyurea in children and young adults with sickle cell disease

21 January 2018

1 reference

How I use hydroxyurea to treat young patients with sickle cell anemia

21 January 2018

1 reference

Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea

21 January 2018

1 reference

Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy

21 January 2018

1 reference

Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia

21 January 2018

1 reference

Use of hydroxyurea in prevention of stroke in children with sickle cell disease.

21 January 2018

1 reference

The natural history of conditional transcranial Doppler flow velocities in children with sickle cell anaemia

21 January 2018

1 reference

Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience.

21 January 2018

1 reference

Hydroxyurea: An alternative to transfusion therapy for stroke in sickle cell anemia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.22142

1 reference

26 February 2018

1 reference

26 February 2018